Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.66 USD | -0.25% | -0.41% | -15.80% |
Apr. 30 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
Mar. 08 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.80% | 1.36B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Morgan Stanley Adjusts Akero Therapeutics Price Target to $26 From $29, Maintains Equalweight Rating